Cancer, Advanced Completed Phase 1 Trials for Erlotinib (DB00530)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01287546A Study of LY2875358 in Participants With Advanced CancerTreatment
NCT00895687Study of Erlotinib in Combination With BortezomibTreatment
NCT00895128Study of Erlotinib in Combination With DasatinibTreatment